IMAX at an All-Time High: A $3 Billion Prize Nobody Can Easily Buy

IMAX is riding one of the most remarkable post-pandemic comebacks in entertainment, and a potential sale — floated by CEO Rich Gelfond in December — now looks far more complicated than it did nine months ago. The company hasn't hired new bankers or formalized a pitch book, and with its stock hitting an all-time high of $54.79 this week — up nearly 80% in the past 12 months — the asking price has ballooned by roughly $1 billion since Gelfond first opened the door to a deal.

The financial case for IMAX as a standalone business is hard to argue with. Christopher Nolan and Universal's 'The Odyssey' just became the first film in IMAX history to surpass $400 million in global IMAX ticket sales — representing nearly 30% of the film's total worldwide gross despite IMAX screens making up less than 1% of screens globally. Wall Street analysts expect IMAX to post another record global box office in 2026, building on the $1.28 billion it recorded in 2025 — itself more than 40% above 2024 and 13% ahead of the prior record set in 2019. Pre-sales for Denis Villeneuve's 'Dune: Part Three,' due in December from Warner Bros., have already sold out specialized screenings into January.

Premium pricing hasn't slowed demand. The average adult IMAX ticket in the U.S. runs $20.57 in 2026 — more than 60% above the standard $12.75 ticket and nearly 18% above rival premium large-format offerings at $17.46. Between 160 and 175 new IMAX systems are slated for installation this year alone, with contracts for hundreds more already signed. The company is also diversifying geographically, building partnerships in China, Japan, and South Korea to screen local-language content.

The strategic puzzle for any would-be buyer is thorny. Major studios — Disney, Universal, Paramount, Warner Bros. — face an obvious conflict of interest: IMAX is explicitly studio-agnostic, giving every studio equal access to premium release slots. If one studio owned IMAX, rivals would reasonably fear being deprioritized during the all-important holiday and summer windows. Filling a 52-week IMAX calendar with a single studio's output would also be nearly impossible. Tech and streaming giants like Netflix, Apple, Amazon, and Sony have been floated as more neutral acquirers whose content businesses could benefit from owning a premium theatrical distribution platform. Netflix, notably, recently entered M&A mode — bidding on Warner Bros. Discovery's studio and streaming assets before being outbid by Paramount Skydance — signaling an appetite for deals it long resisted. Private equity is also seen as a clean option, free from studio-conflict baggage and well-positioned to ride IMAX's growth curve.

For now, IMAX can afford to wait. Wedbush analyst Alicia Reese puts it plainly: the company is not desperate, and its executives won't settle for anything short of a meaningful premium above current trading levels — a high bar when the stock is already near all-time highs. B. Riley's Drew Crum raised his price target to $61 this week, and some firms see it reaching $65. With record financials forecast, expanding margins, and a global footprint few entertainment companies can match, IMAX appears content to let suitors come to it — on its terms.